However, since improving insulin sensitivity would allow patients to reduce their insulin doses, prophylactic NAC therapy may be very efficacious for patients with T1 or T2DM both in terms of preventing HAAF and improving overall health. This evidence concerns the gene INS and type 2 diabetes mellitus.